46 Matching Annotations
  1. Aug 2026
    1. In all five cases, Cas9 programmed with these chimeric RNAs efficiently cleaved the plasmid at the correct target site (Fig. 5D and fig. S15D), indicating that rational design of chimeric RNAs is robust and could, in principle, enable targeting of any DNA sequence of interest

      The design of single "chimeric RNAs" was presented as an add on to the core findings of this paper. Today, the design of single guide RNA (sgRNA) and dual guide RNA (dgRNA) for CRISPR-Cas system has become a subfield of bioengineering that has inspired new basic biochemistry questions about the function of endogenous CRISPR-Cas systems. This month, a paper was published that identifies a new Cas9 structural motif called the guide repeat clasp (GRC) motif which helps to coordinate R-loop sensing and enable dsDNA cleavage (Chilamkurthy et al., 2026 Nucleic Acids Research). The research was motivated by observed differences between endogenous dgRNA and engineered sgRNA editing efficiency and specificity. It is really interesting to me that the authors pursued the design of single guide RNAs in this core paper and didn't save it for future research. It is one of the things that makes this paper excellent.

    2. Finally, to establish whether the design of chimeric RNA might be universally applicable, we engineered five different chimeric guide RNAs to target a portion of the gene encoding the green-fluorescent protein (GFP)

      This is a really elegant experiment; editing the reporter gene (GFP) is an easy way to verify the activity. It can also be done in vitro which eliminates a lot of possible confounding variables in the experiment. Eliminating confounders can enable drawing conclusions with less experiments, in vivo experiments can often require secondary and tertiary evidence to please the reviewers. Other authors have used similar approaches to verify TF-promoter interactions using plasmids transformed into a Nicotiana benthamiana system (Chenxin et al., 2026 New Phytologist). This experiment used reporters to verify TF-promoter interactions from Catharanthus roseus outside of their native environment. Although the experiments were different, both are creative uses of reporters and synthetic biology (plasmids) to confirm biochemical interactions and functions of particular molecules.

  2. Sep 2024
  3. Jul 2024
  4. Aug 2022
  5. Apr 2022
  6. Mar 2022
  7. Dec 2021
  8. Oct 2021
    1. Wickenhagen, A., Sugrue, E., Lytras, S., Kuchi, S., Noerenberg, M., Turnbull, M. L., Loney, C., Herder, V., Allan, J., Jarmson, I., Cameron-Ruiz, N., Varjak, M., Pinto, R. M., Lee, J. Y., Iselin, L., Palmalux, N., Stewart, D. G., Swingler, S., Greenwood, E. J. D., … Wilson, S. J. (n.d.). A prenylated dsRNA sensor protects against severe COVID-19. Science, 0(0), eabj3624. https://doi.org/10.1126/science.abj3624

  9. May 2021
  10. Apr 2021
  11. Mar 2021
  12. Jan 2021
    1. The finding is the latest in a series of discoveries, over the past several years, pointing to the possibility that DNA and its close chemical cousin RNA arose together as products of similar chemical reactions, and that the first self-replicating molecules—the first life forms on Earth—were mixes of the two.

      early molecules

  13. Dec 2020
    1. Transfection commonly refers to the introduction of nucleic acids into eukaryotic cells, or more specifically, into animal cells. Classically, the term transfection was used to denote the uptake of viral nucleic acid from a prokaryote‑infecting virus or bacteriophage, resulting in an infection and the production of mature virus particles. However, the term has acquired its present meaning to include any artificial introduction of foreign nucleic acid into a cell.

      Artificially introducing RNA into cells by means other than a virus or bacteriophage.

  14. Nov 2020
  15. Oct 2020
  16. Sep 2020
  17. Aug 2020
  18. Jul 2020
    1. Mulligan, M. J., Lyke, K. E., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S. P., Neuzil, K., Raabe, V., Bailey, R., Swanson, K. A., Li, P., Koury, K., Kalina, W., Cooper, D., Fonter-Garfias, C., Shi, P.-Y., Tuereci, O., Tompkins, K. R., Walsh, E. E., … Jansen, K. U. (2020). Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report. MedRxiv, 2020.06.30.20142570. https://doi.org/10.1101/2020.06.30.20142570

    1. That does not mean that there is infectious virus present. (This distinction has confused a great number of reports about the persistence of the virus on surfaces as well). We still don’t know how long infected patients (symptomatic and asymptomatic) are shedding infectious virus – those are far harder data points to obtain than just detecting viral RNA.
  19. May 2020
  20. Apr 2020
  21. Oct 2019
  22. Oct 2018
  23. Sep 2018
  24. Jun 2018
  25. Mar 2018
  26. Feb 2018
  27. Nov 2017
  28. Oct 2017
  29. Nov 2016